Penn Medicine team reports on study of first 59 leukemia patients who received cell therapy

Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the University of Pennsylvania will announce the latest data on 59 adults and children with advanced blood cancers that have failed to respond to standard therapies. Results in patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Socie…

Fuente : http://www.eurekalert.org/pub_releases/2013-12/uop…



Hacer un comentario